Webbplats analys beigene.com
Advancing Cancer Care Through Science & Purpose | BeOne Medicines
Genereras på Mars 16 2026 20:57 PM
Gammal statistik? UPDATERA !
Ställningen är 54/100
SEO Innehåll
Titel
Advancing Cancer Care Through Science & Purpose | BeOne Medicines
Längd : 65
Perfekt, din titel innehåller mellan 10 och 70 tecken.
Beskrivning
BeOne Medicines, formerly BeiGene, is committed to advancing cancer care through a science‑led, purpose‑driven model that improves treatment access for patients worldwide.
Längd : 171
Idealisk, din metabeskrivning bör innehålla mellan 70 och 160 tecken (mellanslag räknas som tecken). Använd denna gratis verktyg för att räkna ut textlängden.
Nyckelord
Mycket dåligt. Vi har inte lyckats hitta några meta-taggar på din sida. Använd denna meta-tag generator, gratis för att skapa nyckelord.
Og Meta Egenskaper
Bra, din sida drar nytta utav Og.
| Egendom | Innehåll |
|---|---|
| locale | en_US |
| type | website |
| title | Advancing Cancer Care Through Science & Purpose | BeOne Medicines |
| description | BeOne Medicines, formerly BeiGene, is committed to advancing cancer care through a science‑led, purpose‑driven model that improves treatment access for patients worldwide. |
| url | https://beonemedicines.com/ |
| site_name | BeOne |
Rubriker
| H1 | H2 | H3 | H4 | H5 | H6 |
| 1 | 7 | 1 | 16 | 0 | 14 |
- [H1] Transforming How The World Fights Cancer
- [H2] Leading Cancer Research Worldwide
- [H2] Driving Change for People With Cancer
- [H2] BeOne News
- [H2] Be You. Be Change. BeOne.
- [H2] Participate in Research
- [H2] EXTERNAL LINKS
- [H2] EXTERNAL LINKS
- [H3] Discover our nearly 50 abstracts at ASH 2025.
- [H4] Living with Cancer: Richard’s Story
- [H4] Living with Cancer: Geoff and Tina’s story
- [H4] Building a Breast Cancer Pipeline With Purpose
- [H4] A Culture That Enables Innovation
- [H4] BeOne Medicines Announces Fourth Quarter and Full Year 2025 Financial Results, Highlighting…
- [H4] BeOne Medicines to Present at Upcoming Investor Conferences
- [H4] BeOne Medicines to Announce Fourth Quarter and Full Year 2025 Financial Results…
- [H4] BeOne Medicines Highlights Global Oncology Leadership at 44th Annual J.P. Morgan Healthcare…
- [H4] ZIIHERA Plus TEVIMBRA and Chemotherapy: A Potential New Standard for First-Line HER2+…
- [H4] BeOne Medicines’ Novel BCL2 Inhibitor, Sonrotoclax, Achieves First-in-World Approval in R/R MCL…
- [H4] BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference
- [H4] BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment…
- [H4] BRUKINSA Delivers Landmark 74% 6-Year PFS in Patients with Treatment-Naïve Chronic Lymphocytic…
- [H4] Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies
- [H4] U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed…
- [H4] BeOne Medicines Showcases Leadership in B-cell Malignancies at ASH 2025
- [H6] February 26, 2026
- [H6] February 17, 2026
- [H6] February 11, 2026
- [H6] January 13, 2026
- [H6] January 6, 2026
- [H6] January 6, 2026
- [H6] December 23, 2025
- [H6] December 18, 2025
- [H6] December 8, 2025
- [H6] December 7, 2025
- [H6] November 26, 2025
- [H6] November 20, 2025
- [H6] Careers
- [H6] Clinical Trials
Bilder
Vi hittade 14 bilder på denna webbsida.
Bra, de flesta eller alla dina bilder innehåller alt-attribut
Text/HTML Ratio
Ratio : 11%
Denna sidas förhållande mellan text till HTML-kod är lägre än 15 procent, vilket innebär att din webbplats troligen behöver mer textinnehåll.
Flash
Perfekt, inga Flash-innehåll har upptäckts på denna sida.
Iframe
Synd, du har Iframes på webbsidorna vilket innebär att innehållet i en Iframe inte kan indexeras.
SEO Länkar
URL Rewrite
Bra. Dina adressfält ser bra ut!
Understreck i URLen
Perfekt! Inga understreck upptäcktes i din webbadress.
In-page länkar
Vi hittade totalt 82 länkar inklusive 0 länk(ar) till filer
| Anchor | Typ | Juice |
|---|---|---|
| Contact Us | Interna | Passing Juice |
| Adverse Events | Interna | Passing Juice |
| Newsroom | Interna | Passing Juice |
| Corporate Press Kit | Interna | Passing Juice |
| Product & Pipeline Media Resources | Externa | Passing Juice |
| Media Library | Interna | Passing Juice |
| Global | Interna | Passing Juice |
| Argentina | Externa | Passing Juice |
| Australia | Externa | Passing Juice |
| Austria | Externa | Passing Juice |
| Brazil | Externa | Passing Juice |
| EN | Externa | Passing Juice |
| FR | Externa | Passing Juice |
| China | Externa | Passing Juice |
| Denmark | Externa | Passing Juice |
| Finland | Externa | Passing Juice |
| France | Externa | Passing Juice |
| Germany | Externa | Passing Juice |
| Italy | Externa | Passing Juice |
| Japan | Externa | Passing Juice |
| MENA | Externa | Passing Juice |
| Netherlands | Externa | Passing Juice |
| Norway | Externa | Passing Juice |
| Singapore | Externa | Passing Juice |
| South Africa | Externa | Passing Juice |
| South Korea | Externa | Passing Juice |
| Spain | Externa | Passing Juice |
| Sweden | Externa | Passing Juice |
| DE | Externa | Passing Juice |
| FR | Externa | Passing Juice |
| IT | Externa | Passing Juice |
| UK | Externa | Passing Juice |
| United States | Externa | Passing Juice |
| About Us | Interna | Passing Juice |
| Our History | Interna | Passing Juice |
| Leadership | Interna | Passing Juice |
| Our Stories | Interna | Passing Juice |
| Our Offices | Interna | Passing Juice |
| Partnering | Interna | Passing Juice |
| Manufacturing | Interna | Passing Juice |
| Our Medicines | Interna | Passing Juice |
| Research & Development Overview | Interna | Passing Juice |
| Disease Focus Areas: Hematology | Interna | Passing Juice |
| Disease Focus Areas: Solid Tumors | Interna | Passing Juice |
| Pioneering Protein Degradation with CDACs | Externa | Passing Juice |
| Antibody Drug Conjugates | Externa | Passing Juice |
| Pipeline | Interna | Passing Juice |
| Find a Trial | Interna | Passing Juice |
| Becoming an Investigator | Interna | Passing Juice |
| Investigator-Initiated Trial | Interna | Passing Juice |
| BeCollective HCP Network | Interna | Passing Juice |
| Collaborations | Externa | Passing Juice |
| Our Commitment to Patients | Interna | Passing Juice |
| Patient Support Program | Interna | Passing Juice |
| Expanded Access Program | Interna | Passing Juice |
| Cancer & Mental Health | Interna | Passing Juice |
| Global Patient Safety | Interna | Passing Juice |
| Responsibility and Sustainability | Interna | Passing Juice |
| Advancing Global Health | Interna | Passing Juice |
| Empowering Our Colleagues | Interna | Passing Juice |
| Innovating Sustainably | Interna | Passing Juice |
| Operating Responsibly Overview | Externa | Passing Juice |
| Policies & Positions | Interna | Passing Juice |
| Suppliers | Interna | Passing Juice |
| Global Transparency | Interna | Passing Juice |
| Giving Overview | Externa | Passing Juice |
| BeOne Care Foundation | Interna | Passing Juice |
| Independent Medical Education Grants | Interna | Passing Juice |
| Careers | Interna | Passing Juice |
| Our Culture | Interna | Passing Juice |
| Visit our congress hub to learn more | Externa | Passing Juice |
| Contact Us | Interna | Passing Juice |
| Newsroom | Interna | Passing Juice |
| NASDAQ Investors | Externa | Passing Juice |
| HKEX Investors | Externa | Passing Juice |
| SSE Investors | Externa | Passing Juice |
| Medical Information | Externa | Passing Juice |
| NASDAQ Investors | Interna | Passing Juice |
| HKEX Investors | Interna | Passing Juice |
| SSE Investors | Interna | Passing Juice |
| Terms of Use | Interna | Passing Juice |
| Privacy Policy | Interna | Passing Juice |
SEO Nyckelord
Nyckelord Moln
global media world newsroom press south beone research patients cancer
Nyckelord Konsistens
| Nyckelord | Innehåll | Titel | Nyckelord | Beskrivning | Rubriker |
|---|---|---|---|---|---|
| global | 8 |  |
|
|
 |
| cancer | 6 | |
|
|
|
| newsroom | 5 | |
|
|
|
| press | 5 | |
|
|
|
| beone | 4 | |
|
|
|
Användbarhet
Url
Domän : beigene.com
Längd : 11
Favikon
Bra, din webbplats har en favicon.
Utskriftbart
Vi kunde inte hitta CSS för utskrifter.
Språk
Bra. Ditt angivna språk är en.
Dublin Core
Denna sida drar inte nytta utav Dublin Core.
Dokument
Doctype
HTML 5
Encoding
Perfekt. Din deklarerade teckenuppsättning är UTF-8.
W3C Validity
Errors : 0
Varningar : 0
E-post Sekretess
Varning! Minst en e-postadress har påträffats i klartext. Använd gratis antispam skydd för att dölja e-post från spammare.
Föråldrad HTML
Bra! Vi har inte hittat några föråldrad HTML taggar i din HTML.
Hastighets Tips
|
Utmärkt, din webbplats använder inga nästlade tabeller. |
|
Synd, din webbplats använder sig utav inline stilar. |
|
Synd, din webbplats har för många CSS-filer (fler än 4 stycken). |
|
Synd, din webbplats har för många JS filer (fler än 6 stycken). |
|
Perfekt, din webbplats utnyttjar gzip. |
Mobil
Mobiloptimering
|
Apple Ikon |
|
Meta Viewport Tagg |
|
Flash innehåll |
Optimering
XML Sitemap
Bra, din webbplats har en XML sitemap.
| https://beonemedicines.com/sitemap_index.xml |
Robots.txt
https://beigene.com/robots.txt
Bra, din webbplats har en robots.txt fil.
Analytics
Saknas
Vi hittade inte någon analysverktyg på din webbplats.
Webbanalys program kan mäta besökare på din webbplats. Du bör ha minst ett analysverktyg installerat, men det kan också vara en bra ide att installera två för att dubbelkolla uppgifterna.
PageSpeed Insights
Enhet
Kategorier
Free SEO Testing Tool
Free SEO Testing Tool är en fri SEO verktyg som hjälper dig att analysera din webbplats